Congenitally underdeveloped intestine drives autism-related gut microbiota and behavior

Brain Behav Immun. 2022 Oct:105:15-26. doi: 10.1016/j.bbi.2022.06.006. Epub 2022 Jun 14.

Abstract

Autism spectrum disorder (ASD) is a neurological and developmental disorder accompanied by gut dysbiosis and gastrointestinal symptoms in most cases. However, the development of the autism-related gut microbiota and its relationship with intestinal dysfunction in ASD remain unclear. Using a valproic acid (VPA)-induced ASD mouse model, we showed a congenitally immature intestine of VPA-exposed mice accompanied by prominent oxidative stress and inflammation. Of note, the gut microbiota composition of VPA-exposed mice resembled that of control mice within 24 h after birth; however, their gut microbiota compositions differed on postnatal days 7 and 21. Oral administration of superoxide dismutase (SOD) to attenuate intestinal oxidative stress either before weaning or during juvenile restored the autism-associated gut microbiota, leading to the amelioration of autism-related behaviors. These findings collectively suggest the congenitally underdeveloped intestine as an early driving force shaping the autism-associated gut microbiota and host neurodevelopment through enhancing oxidative stress.

Keywords: Autism spectrum disorder; Behavior; Gut microbiota; Oxidative stress; Superoxide dismutase; Underdeveloped intestine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autism Spectrum Disorder*
  • Autistic Disorder*
  • Dysbiosis
  • Gastrointestinal Diseases*
  • Gastrointestinal Microbiome*
  • Intestines
  • Mice
  • Valproic Acid

Substances

  • Valproic Acid